Broadwood opposes Alcon's STAAR Surgical acquisition bid
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/7/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Broadwood Partners Condemns Alcon’s Fallacious Attacks on STAAR Surgical and Its Prospects
November 4, 2025 11:52 AM ESTReminds STAARs Board That It Does Not Need Alcons Permission to Remain Independent or Run a Proper Strategic Alternatives Process
NEW YORK--(BUSINESS WIRE)-- Broadwood Partners, L.P. and its affiliates (Broadwood or we) today commented on the investor presentation issued by Alcon Inc. (Alcon) (NYSE: ALC) regarding its proposed acquisition of STAAR Surgical Company (STAAR or the Company) (NASDAQ: STAA). Broadwood, which owns 27.5% of STAARs outstanding common stock, continues to urge its fellow shareholders to vote on its GREEN Proxy... More
